Tissue Genesis Introduces State-of-the-Art Icellator(R) X

-- The enhanced enzyme-derived stem cell isolation system offers a greater overall impact and efficiency in the field of regenerative medicine

Tissue Genesis LLC announced today the release of the Icellator(R) X, the newest and most advanced system for isolating stem cells in adipose tissue.

The Icellator(R) X expands on the capabilities of the original Icellator(R), representing a major advancement in the real-world application of stem therapies for patients.

The new-to-market Icellator(R) X offers greater stem cell yields, improved ease of use, and a user interface available in multiple languages. It is immediately the most efficient system available on the market. The 2019 Icellator(R) X lets medical professionals and scientists rapidly recover millions of a patient's own adult stem cells for therapeutic treatments and research applications.

The Icellator(R) X is on exhibit at the 16th-annual iFats (International Federation for Adipose Therapeutics and Science) Conference at the Cosmopolitan Las Vegas from Dec. 13-15. (Booth #302)

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).